跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,749 条关于
“Multi-Pill Abuse Resistance”
全部
41,749
临床试验
33,575
药物
443
机构
69
资讯
7,662
去年
Ensysce Biosciences Secures Patent for Novel Methadone-Based Opioid Use Disorder Treatment
9个月前
Ensysce Biosciences Enrolls First Patient in Pivotal Phase 3 Trial for Abuse-Resistant Opioid PF614
去年
Ensysce Biosciences Secures Supply and Partnership to Advance Abuse-Resistant Pain Relief
9个月前
Ensysce Biosciences Secures Extended Patent Protection for MPAR Overdose Prevention Technology Through 2042
3年前
Ensysce Biosciences Advances Abuse-Deterrent and Overdose-Protection Opioid Programs
去年
Ensysce Biosciences Advances Abuse-Resistant Opioids PF614 and PF614-MPAR Towards Market
去年
Ensysce Biosciences Strengthens Regulatory Team Ahead of Critical Phase 3 Trials and NDA Submission
去年
Ensysce Biosciences Secures Patent for Novel Opioid Use Disorder Treatment PF9001
去年
Trevi Therapeutics' Oral Nalbuphine Demonstrates Reduced Abuse Potential in Clinical Study
去年
FDA Approves Abuse-Deterrent Roxybond 10mg for Pain Management
第 1 页，共 767 页
上一页
下一页
